| RS2102413026 |
LAMB3
|
Health Risk |
Pathogenic |
— |
| RS2102413223 |
LAMB3
|
Health Risk |
Likely pathogenic |
— |
| RS2102413524 |
DSTYK
|
Health Risk |
Likely pathogenic |
Congenital anomalies of kidney and urinary tract 1, Congenital anomalies of kidney and urinary tract 1 |
| RS2102414095 |
CENPF
|
Health Risk |
Likely pathogenic |
Stromme syndrome, Stromme syndrome |
| RS2102415377 |
PTPRC
|
Health Risk |
Likely pathogenic |
Immunodeficiency 104, Immunodeficiency 104 |
| RS2102416154 |
LAMB3
|
Health Risk |
Likely pathogenic |
— |
| RS2102416503 |
LAMB3
|
Health Risk |
Pathogenic |
— |
| RS2102419503 |
CENPF
|
Health Risk |
Pathogenic |
Neurodevelopmental delay, Neurodevelopmental delay |
| RS2102420104 |
LAMB3
|
Health Risk |
Pathogenic |
— |
| RS2102420131 |
LAMB3
|
Health Risk |
Pathogenic |
— |
| RS2102420949 |
LAMB3
|
Health Risk |
Pathogenic |
— |
| RS2102423955 |
LAMB3
|
Health Risk |
Likely pathogenic |
— |
| RS2102424137 |
LAMB3
|
Health Risk |
Pathogenic |
— |
| RS2102424525 |
LAMB3
|
Health Risk |
Pathogenic |
Abnormality of the skin, Abnormality of the skin |
| RS2102430895 |
LAMB3
|
Health Risk |
Pathogenic |
— |
| RS2102434789 |
LAMB3
|
Health Risk |
Pathogenic |
— |
| RS2102438416 |
LAMB3
|
Health Risk |
Pathogenic |
— |
| RS2102438650 |
LAMB3
|
Health Risk |
Pathogenic/Likely pathogenic |
Junctional epidermolysis bullosa gravis of Herlitz, Junctional epidermolysis bullosa gravis of Herlitz |
| RS2102440742 |
USH2A
|
Health Risk |
Pathogenic |
Retinitis pigmentosa 39, Retinal dystrophy |
| RS2102440764 |
USH2A
|
Health Risk |
Pathogenic |
Usher syndrome type 2A, Usher syndrome type 2A |
| RS2102444886 |
LAMB3
|
Health Risk |
Pathogenic |
— |
| RS2102445016 |
PTPRC
|
Health Risk |
Pathogenic |
Immunodeficiency 104, Immunodeficiency 104 |
| RS2102446289 |
LAMB3
|
Health Risk |
Pathogenic |
— |
| RS2102446425 |
LAMB3
|
Health Risk |
Likely pathogenic |
— |
| RS2102450642 |
USH2A
|
Health Risk |
Pathogenic |
Retinitis pigmentosa 39, Retinitis pigmentosa 39 |
| RS2102450680 |
USH2A
|
Health Risk |
Pathogenic |
— |
| RS2102450707 |
USH2A
|
Health Risk |
Pathogenic |
— |
| RS2102450764 |
USH2A
|
Health Risk |
Pathogenic |
Usher syndrome type 2A, Usher syndrome type 2A |
| RS2102451639 |
USH2A
|
Health Risk |
Pathogenic |
— |
| RS2102451648 |
USH2A
|
Health Risk |
Pathogenic/Likely pathogenic |
Usher syndrome type 2A, Retinitis pigmentosa 39 |
| RS2102451706 |
USH2A
|
Health Risk |
Pathogenic |
— |
| RS2102451863 |
USH2A
|
Health Risk |
Pathogenic |
Usher syndrome type 2A, Usher syndrome type 2A |
| RS2102452018 |
USH2A
|
Health Risk |
Likely pathogenic |
Usher syndrome type 2A, Usher syndrome type 2A |
| RS2102453751 |
USH2A
|
Health Risk |
Pathogenic |
— |
| RS2102455183 |
NPHP4
|
Health Risk |
Likely pathogenic |
Nephronophthisis, Nephronophthisis |
| RS2102458321 |
USH2A
|
Health Risk |
Likely pathogenic |
Retinitis pigmentosa 39, Usher syndrome type 2A |
| RS2102458324 |
USH2A
|
Health Risk |
Likely pathogenic |
— |
| RS2102458388 |
USH2A
|
Health Risk |
Pathogenic |
Usher syndrome type 2A, Usher syndrome type 2A |
| RS2102458475 |
USH2A
|
Health Risk |
Pathogenic |
Usher syndrome type 2A, Usher syndrome type 2A |
| RS2102460193 |
USH2A
|
Health Risk |
Pathogenic |
Retinitis pigmentosa 39, Usher syndrome type 2A |
| RS2102460222 |
USH2A
|
Health Risk |
Pathogenic |
— |
| RS2102460236 |
USH2A
|
Health Risk |
Pathogenic/Likely pathogenic |
Retinitis pigmentosa 39, Usher syndrome |
| RS2102460239 |
USH2A
|
Health Risk |
Pathogenic/Likely pathogenic |
Usher syndrome type 2A, Retinitis pigmentosa 39 |
| RS2102460254 |
USH2A
|
Health Risk |
Pathogenic |
— |
| RS2102460377 |
USH2A
|
Health Risk |
Pathogenic |
— |
| RS2102460381 |
USH2A
|
Health Risk |
Pathogenic/Likely pathogenic |
Usher syndrome, Usher syndrome type 2A |
| RS2102460635 |
USH2A
|
Health Risk |
Pathogenic |
— |
| RS2102460644 |
USH2A
|
Health Risk |
Pathogenic |
— |
| RS2102460761 |
USH2A
|
Health Risk |
Likely pathogenic |
Usher syndrome type 2A, Usher syndrome type 2A |
| RS2102463667 |
USH2A
|
Health Risk |
Likely pathogenic |
— |
| RS2102463697 |
USH2A
|
Health Risk |
Likely pathogenic |
— |
| RS2102463707 |
USH2A
|
Health Risk |
Pathogenic |
— |
| RS2102464077 |
USH2A
|
Health Risk |
Pathogenic |
— |
| RS2102464166 |
USH2A
|
Health Risk |
Pathogenic/Likely pathogenic |
Usher syndrome type 2A, Retinal dystrophy |
| RS2102464224 |
USH2A
|
Health Risk |
Pathogenic |
— |
| RS2102464376 |
USH2A
|
Health Risk |
Pathogenic |
— |
| RS2102464408 |
USH2A
|
Health Risk |
Pathogenic/Likely pathogenic |
Retinitis pigmentosa 39, Retinitis pigmentosa 39 |
| RS2102466345 |
USH2A
|
Health Risk |
Pathogenic |
— |
| RS2102466384 |
USH2A
|
Health Risk |
Pathogenic |
— |
| RS2102466420 |
USH2A
|
Health Risk |
Likely pathogenic |
Retinitis pigmentosa 39, Retinal dystrophy |
| RS2102466516 |
USH2A
|
Health Risk |
Pathogenic |
— |
| RS2102467034 |
USH2A
|
Health Risk |
Pathogenic/Likely pathogenic |
Retinitis pigmentosa 39, Retinitis pigmentosa 39 |
| RS2102467762 |
LAMB3
|
Health Risk |
Likely pathogenic |
Junctional epidermolysis bullosa gravis of Herlitz, Junctional epidermolysis bullosa gravis of Herlitz |
| RS2102469461 |
USH2A
|
Health Risk |
Pathogenic |
— |
| RS2102469493 |
USH2A
|
Health Risk |
Pathogenic |
Retinitis pigmentosa 39, Usher syndrome type 2A |
| RS2102469649 |
USH2A
|
Health Risk |
Pathogenic |
Usher syndrome type 2A, Usher syndrome type 2A |
| RS2102470099 |
USH2A
|
Health Risk |
Likely pathogenic |
— |
| RS2102470142 |
USH2A
|
Health Risk |
Conflicting classifications of pathogenicity |
Retinitis pigmentosa 39, Retinitis pigmentosa 39 |
| RS2102470145 |
USH2A
|
Health Risk |
Pathogenic |
— |
| RS2102475830 |
PTPRC
|
Health Risk |
Likely pathogenic |
Immunodeficiency 104, Immunodeficiency 104 |
| RS2102476647 |
USH2A
|
Health Risk |
Pathogenic |
— |
| RS2102480253 |
ADIPOR1
|
Health Risk |
Pathogenic |
— |
| RS2102480814 |
USH2A
|
Health Risk |
Pathogenic |
Usher syndrome type 2A, Usher syndrome type 2A |
| RS2102481774 |
USH2A
|
Health Risk |
Pathogenic/Likely pathogenic |
Retinitis pigmentosa 39, Retinal dystrophy |
| RS2102481922 |
USH2A
|
Health Risk |
Pathogenic |
— |
| RS2102482051 |
USH2A
|
Health Risk |
Likely pathogenic |
Retinitis pigmentosa 39, Retinitis pigmentosa 39 |
| RS2102483177 |
USH2A
|
Health Risk |
Pathogenic/Likely pathogenic |
Retinitis pigmentosa 39, Retinitis pigmentosa 39 |
| RS2102483271 |
USH2A
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS2102483305 |
USH2A
|
Health Risk |
Likely pathogenic |
Usher syndrome type 2A, Usher syndrome type 2A |
| RS2102489197 |
NAXE
|
Health Risk |
Pathogenic |
Encephalopathy, progressive |
| RS2102489248 |
NAXE
|
Health Risk |
Pathogenic |
Encephalopathy, progressive |
| RS2102491191 |
NAXE
|
Health Risk |
Likely pathogenic |
Encephalopathy, progressive |
| RS2102491600 |
DPM3
|
Health Risk |
Pathogenic |
DPM3-congenital disorder of glycosylation, DPM3-congenital disorder of glycosylation |
| RS2102492616 |
USH2A
|
Health Risk |
Likely pathogenic |
Usher syndrome type 2A, Usher syndrome type 2A |
| RS2102494691 |
TARS2
|
Health Risk |
Pathogenic/Likely pathogenic |
Combined oxidative phosphorylation defect type 21, Combined oxidative phosphorylation defect type 21 |
| RS2102496332 |
USH2A
|
Health Risk |
Pathogenic |
— |
| RS2102499681 |
USH2A
|
Health Risk |
Pathogenic |
— |
| RS2102499717 |
USH2A
|
Health Risk |
Pathogenic |
Usher syndrome type 2A, USH2A-related disorder |
| RS2102499727 |
USH2A
|
Health Risk |
Pathogenic |
— |
| RS2102499747 |
CACNA1E
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, Developmental and epileptic encephalopathy |
| RS2102499800 |
USH2A
|
Health Risk |
Pathogenic |
— |
| RS2102499826 |
USH2A
|
Health Risk |
Likely pathogenic |
Retinitis pigmentosa 39, Retinitis pigmentosa 39 |
| RS2102504055 |
SLC41A1
|
Health Risk |
Pathogenic |
Nephronophthisis-like nephropathy 2, Nephronophthisis-like nephropathy 2 |
| RS2102509840 |
CACNA1E
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS2102510285 |
TARS2
|
Health Risk |
Likely pathogenic |
Combined oxidative phosphorylation defect type 21, Combined oxidative phosphorylation defect type 21 |
| RS2102512645 |
CD46
|
Health Risk |
Conflicting classifications of pathogenicity |
Atypical hemolytic-uremic syndrome, Atypical hemolytic-uremic syndrome |
| RS2102522151 |
USH2A
|
Health Risk |
Pathogenic |
Ear malformation, Ear malformation |
| RS2102522326 |
USH2A
|
Health Risk |
Pathogenic |
— |
| RS2102524828 |
USH2A
|
Health Risk |
Pathogenic |
Usher syndrome type 2A, Usher syndrome type 2A |
| RS2102524917 |
USH2A
|
Health Risk |
Pathogenic |
— |